http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109939172-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee6040847fb8b93a483eb269d1fc62f3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8967 |
| filingDate | 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a045cb152e14f56c2bb3f6a1f0214ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee262d33b2b4b90a88c16bc64e0f407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f62eaf89dc63887d02b48e83ec3017 |
| publicationDate | 2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109939172-A |
| titleOfInvention | A kind of drug and preparation method thereof for stable phase of chronic obstructive pulmonary disease |
| abstract | The drug and preparation method thereof that the invention discloses a kind of for stable phase of chronic obstructive pulmonary disease, effective medicinal components are made of astragalus root, sun-dried ginseng, lily, the root bark of Chinese wolf-berry, ephedra, almond, Rhizoma Atractylodis Macrocephalae, gekko, fritillaria thunbergii, Snakegourd Seed, radices trichosanthis, Poria cocos, dried orange peel, campanulaceae, rhizoma pinellinae praeparata, radix glycyrrhizae preparata, rhizoma alismatis, the root bark of tree peony and radix paeoniae rubra.The present invention has effects that qi-restoratives (gas of the gas yin of help lung, invigorating spleen and kidney), resolving sputum dehumidifying Li Shui, activating microcirculation and removing stasis medicinal and nourishing Yin and clearing heat, has both the benefits of promoting the dispersing function of the lung leads to internal organs；For stable phase of chronic obstructive pulmonary disease, immunity of organisms can be improved, reduce the acute exacerbation number of infection-induced；Lung function can also be improved, oxygen is improved and close, control disease progression；Mitigate cough, expectoration, wheeze and dyspnea symptom. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110496181-A |
| priorityDate | 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.